Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01206868
Other study ID # S-06342a
Secondary ID
Status Completed
Phase N/A
First received September 21, 2010
Last updated September 21, 2010
Start date March 2007
Est. completion date May 2009

Study information

Verified date March 2007
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research EthicsNorway: The NorwegianData Inspectorate
Study type Interventional

Clinical Trial Summary

A single centre open randomised parallel-group study to evaluate whether prophylactic fenestration of the peritoneum at the time of renal transplantation prevents lymphocele formation.

Adult (>18 years old) recipients of renal transplants from deceased donors were eligible for inclusion. From March 2007 to May 2009 130 patients were included. The patients were randomized either to peroperative peritoneal fenestration, or to serve as controls. Block-randomization was conducted in groups of 10, drawn from envelopes containing five notes from each group. Patients who previously had undergone extensive abdominal surgery, or were included in other studies were excluded.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date May 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult recipients of kidney transplants from deceased donors

Exclusion Criteria:

- Former extensive abdominal surgery

- Participation in other studies

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Incidence of Symptomatic Lymphocele After Kidney Transplantation
  • Lymphocele
  • Prevalence of Perirenal Fluid Collections at One, Five and Ten Weeks

Intervention

Procedure:
Fenestration
Fenestration of the peritoneum according to the length of the transplanted kidney
Control
Standard kidney transplantation

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of symptomatic lymphoceles Symptomatic lymphoceles treated by surgical intervetion or ultrasound guided drainage 1 - 3 years No
Secondary Prevalence of fluid perirenal collections evaluated by ultrasound at 1, 5 and 10 weeks 1 -10 weeks No